Cellebrite DI (CLBT) Restructuring Costs (2021 - 2025)

Cellebrite DI's Restructuring Costs history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 619.41% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 1627.6% from the prior year.
• Restructuring Costs climbed to $1.6 million in Q4 2025 per CLBT's latest filing, from $164000.0 in the prior quarter.
• Across five years, Restructuring Costs topped out at $1.6 million in Q4 2025 and bottomed at -$323000.0 in Q2 2023.
• The 5-year median for Restructuring Costs is $212000.0 (2024), against an average of $396538.5.
• Across the five-year window, Restructuring Costs sank 181.98% in 2023 and soared 307.69% in 2024, its largest moves.
• Year by year, Restructuring Costs stood at $1.2 million in 2021, then plunged by 88.7% to $133000.0 in 2022, then sank by 60.9% to $52000.0 in 2023, then soared by 307.69% to $212000.0 in 2024, then jumped by 649.06% to $1.6 million in 2025.
• Per Business Quant, the three latest CLBT Restructuring Costs figures stand at $1.6 million (Q4 2025), $164000.0 (Q3 2025), and $212000.0 (Q3 2024).